Role of Tivozanib in Renal Cell Carcinoma (RCC) - Episode 5
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Related Content:
Biomarker Testing ‘Vital’ to Identify Best Treatments for Lung Cancer
Patients With Esophageal Cancer Have ‘More Options’ With Tevimbra
What I Do When My Doctors Don’t Listen
Radiotherapy A Noninvasive Option for Patients With Kidney Cancer